Xilio Development Stock Analysis

Xilio Stock Analysis Notes

About 45.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 0.61. Xilio Development had not issued any dividends in recent years. Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Xilio Therapeutics, Inc. was founded in 2016 and is headquartered in Waltham, Massachusetts. Xilio Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 74 people. For more information please call PharmD BCPS at 857 524 2466 or visit https://xiliotx.com.

Xilio Development Investment Alerts

Xilio Development Upcoming and Recent Events

Xilio Largest EPS Surprises

View All Earnings Estimates

Xilio Stock Institutional Investors

Note, although Xilio Development's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Xilio Market Capitalization

The company currently falls under 'Micro-Cap' category with a total capitalization of 35.26 M.

Xilio Profitablity

The company has Net Profit Margin of (1.84) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of (0.1) %, which entails that for every $100 of revenue, it lost $0.1.

Management Efficiency

Xilio Development has Return on Asset of (0.2626) % which means that on every $100 spent on assets, it lost $0.2626. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (9.0828) %, meaning that it generated no profit with money invested by stockholders. Xilio Development's management efficiency ratios could be used to measure how well Xilio Development manages its routine affairs as well as how well it operates its assets and liabilities. As of the 5th of January 2026, Return On Tangible Assets is likely to drop to -0.99. In addition to that, Return On Capital Employed is likely to drop to -1.31. At this time, Xilio Development's Total Assets are very stable compared to the past year. As of the 5th of January 2026, Net Tangible Assets is likely to grow to about 127.6 M, while Non Currrent Assets Other are likely to drop about 1.3 M.

Technical Drivers

As of the 5th of January, Xilio Development maintains the Market Risk Adjusted Performance of (0.21), mean deviation of 2.28, and Standard Deviation of 3.07. Relative to fundamental indicators, the technical analysis model lets you check existing technical drivers of Xilio Development, as well as the relationship between them.

Xilio Development Price Movement Analysis

Xilio Development Insider Trading Activities

Xilio Development Outstanding Bonds

Xilio Development Predictive Daily Indicators

Xilio Development Forecast Models

Xilio Development's time-series forecasting models are one of many Xilio Development's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Xilio Development's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Xilio Development Bond Ratings

Xilio Development financial ratings play a critical role in determining how much Xilio Development have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Xilio Development's borrowing costs.

Xilio Development Debt to Cash Allocation

Xilio Development has 8.14 M in debt with debt to equity (D/E) ratio of 0.14, which may show that the company is not taking advantage of profits from borrowing. Xilio Development has a current ratio of 8.99, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Note however, debt could still be an excellent tool for Xilio to invest in growth at high rates of return.

Xilio Development Total Assets Over Time

Xilio Development Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Xilio Development uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Xilio Development Debt Ratio

13.0

It appears that most of the Xilio Development's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Xilio Development's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Xilio Development, which in turn will lower the firm's financial flexibility.

Xilio Development Corporate Bonds Issued

Xilio Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Xilio Development prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Xilio shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Xilio Development. By using and applying Xilio Stock analysis, traders can create a robust methodology for identifying Xilio entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Xilio analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Xilio analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Xilio Development stock analysis indicators help investors evaluate how Xilio Development stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Xilio Development shares will generate the highest return on investment. By understating and applying Xilio Development stock analysis, traders can identify Xilio Development position entry and exit signals to maximize returns.

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xilio Development. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Xilio Stock, please use our How to Invest in Xilio Development guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xilio Development. If investors know Xilio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xilio Development listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Xilio Development is measured differently than its book value, which is the value of Xilio that is recorded on the company's balance sheet. Investors also form their own opinion of Xilio Development's value that differs from its market value or its book value, called intrinsic value, which is Xilio Development's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xilio Development's market value can be influenced by many factors that don't directly affect Xilio Development's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Xilio Development's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xilio Development is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xilio Development's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.